Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.Approval of oral semaglutide ...

Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help.

Novo Nordisk’s oral semaglutide Rybelsus reduced the risk for major adverse cardiovascular events by 14% in people with type ...

Ken’s search for answers brought him to nearly a dozen doctors. After months of tests, he was finally diagnosed with a rare ...

Milestone Pharmaceuticals Inc. is advancing CARDAMYST, a self-administered nasal spray for PSVT. Click here to read why MIST ...

Myocardial ischemia is closely associated with arrhythmogenesis and prognostication in patients with atrial fibrillation (AF). Trimetazidine ameliorates myocardial ischemia through prioritizing ...

Background Atrial fibrillation (AF) is a common sustained cardiac arrhythmia with increasing prevalence and incidence worldwide. However, long-term trends in AF prevalence, incidence, associated risk ...

In the randomized controlled SUPPRESS-AF trial, the efficacy of low-voltage-area (LVA) ablation was highly dependent on the degree of atrial remodeling, while the efficacy was not statistically ...

If you think you're having a heart attack, or maybe even a stroke, it may be atrial fibrillation, or A-Fib. "Atrial fibrillation is an irregular fast heart beat," explained Rainier Ponce, a nurse ...